+674.0%
MRNA vs ZBRA
+103.4%
+570.6%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | ZBRA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +1.8% | +3.5% | +4.8% |
| 7D | -1.1% | -3.4% | +2.3% | +0.1% |
| 30D | +126.1% | -7.4% | +133.5% | +130.1% |
| 3M | +190.0% | +57.5% | +132.5% | +136.2% |
| 6M | +157.2% | +64.0% | +93.2% | +104.6% |
| YTD | +388.2% | +44.3% | +343.9% | +303.6% |
| 1Y | +467.0% | +10.9% | +456.2% | +418.9% |
| 3Y | +36.1% | +37.5% | -1.4% | +13.9% |
| 5Y | -68.0% | -39.7% | -28.3% | -67.1% |
| All | +674.0% | +103.4% | +570.6% | +467.1% |
Cumulative growth
Daily Returns
Daily percentage return beside ZBRA.
Daily Out/Under-Performance
Portfolio return minus ZBRA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ZBRA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded ZBRA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling